Aug
2,
2024
Aug 2, 2024
We are pleased to announce that Lallemand Inc. (through its Swiss affiliate, Danstar Ferment AG) has completed an equity investment in Livzym Biotechnologies (“Livzym”) as part of a strategic collaboration within industrial enzymes.
Livzym has over the last 9 years successfully developed a range of enzymes for mainly food and animal feed applications based on their fungi-based technology platform. The recently commissioned enzyme plant in Tuzla near Istanbul, Turkey provides state-of-the-art enzyme production capabilities. The Lallemand investment in Livzym, alongside equity raised from Turkish investors, will contribute to financing the expansion of the Tuzla plant to meet the growing demand for enzymes. As part of the strategic collaboration, Lallemand will market and distribute Livzym enzymes to customers worldwide and will involve cooperation around the development and production of the enzymes in Turkey.
Commenting on the development, Lars Asferg, President of Lallemand Bio-Ingredients said, “We are committed to making biotechnology one of the answers to the challenges the World faces with respect to nutrition, health and the environment. Lallemand is a major global producer of yeast and entered in 2019 the baking enzyme market with our proprietary “LallZyme” range based on our yeast technology. We have since expanded our enzyme presence with acquisitions of the BASF “Nutrilife” food and “Spartec” bio-fuel enzymes businesses. The strategic collaboration with Livzym and their fungal development and production platform perfectly complements our position within the enzymes sector. The Inclusion of Livzym’s enzymes within Lallemand’s portfolio will enable us to provide our customers with an exciting range of high-performance enzymes”.
Dr. Serdar Uysal, Founder and CEO of Livzym said: “The future of food and agriculture is vital for global sustainability, with biotechnology playing a key role in transforming production technologies. LIVZYM is the first industrial enzyme producer to be based in Turkey enabling us to service customers across the Europe, Asia, Middle East and African regions. We are very excited about our strategic investment partnership with Lallemand, a leading global fermentation company, seeing it as a significant opportunity to advance sustainability and enzyme and alternative protein technologies through our precision fermentation capabilities.”
